Peptide Calculator

Retatrutide Dosage Calculator

Calculate Retatrutide triple-agonist reconstitution, dosing units, and U-100 syringe draw math.

Research Range:0.5 mg – 12.0 mg weekly

Retatrutide Pre-filled Reconstitution Tool

Pre-loaded with common Retatrutide vial size and reconstitution ratios.

U-100 Syringe Standard
Total compound mass
mg
Added diluent
mL
mcg
Standard U-100
Calculation OutputU-100 Calibrated
Draw Exactly To:
10.0Units
Line 10 on your syringe (0.10 mL volume)
Concentration
2.50 mg/mL
Doses per Vial
20 Doses
Visual Syringe Indicator1.0 mL Syringe

Stored locally on your device (No account needed)

What Is Retatrutide?

Retatrutide (code name LY3437943) is an experimental unimolecular triple hormone receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors. Developed for metabolic and obesity research, Retatrutide represents a major evolution beyond dual agonists like Tirzepatide and mono-agonists such as Semaglutide. By engaging glucagon receptors alongside GIP and GLP-1, Retatrutide increases energy expenditure and hepatic lipid metabolism while simultaneously suppressing appetite and delaying gastric emptying.

In laboratory research settings, Retatrutide exhibits an estimated terminal elimination half-life of approximately 6 days (144 hours), making weekly administration standard in preclinical protocols. Precise reconstitution using our peptide calculator is critical because lyophilized Retatrutide powder requires exact diluent ratios of bacteriostatic water to ensure consistent concentration across multi-week trials.

Retatrutide Dosage Chart

When preparing Retatrutide vials for laboratory evaluation, researchers must accurately calculate concentration based on vial mass and diluent volume. Lower concentrations (e.g. adding 3.0 mL of water) reduce volumetric measurement errors on fine U-100 syringe scale graduations when measuring starting doses of 1.0 mg or 2.5 mg. Higher concentrations (e.g. adding 1.0 mL or 2.0 mL) allow smaller liquid injection volumes for higher escalation doses such as 4.0 mg or 8.0 mg.

Vial: 5 mgWater: 2.0 mL
Concentration2.5 mg/mL
Target Dose1.0 mg (1,000 mcg)
Draw to Mark:40.0 Units
Vial: 10 mgWater: 2.0 mL
Concentration5.0 mg/mL
Target Dose2.5 mg (2,500 mcg)
Draw to Mark:50.0 Units
Vial: 10 mgWater: 3.0 mL
Concentration3.33 mg/mL
Target Dose2.5 mg (2,500 mcg)
Draw to Mark:75.0 Units
Vial: 15 mgWater: 3.0 mL
Concentration5.0 mg/mL
Target Dose5.0 mg (5,000 mcg)
Draw to Mark:100.0 Units

How to Reconstitute Retatrutide

Reconstituting lyophilized Retatrutide requires strict aseptic technique to preserve the structural stability of the triple-agonist peptide chain. The secondary and tertiary structure of multi-receptor peptides is vulnerable to mechanical shear forces and thermal degradation.

Visual Standard Operating Procedure

Retatrutide Step-by-Step SOP

1. Sanitize70% Isopropyl swabon vial stoppers2. Draw WaterBacteriostatic waterusing mixing syringe3. Glass WallAim slow streamagainst glass wall4. Swirl GentlyNever shake vialSwirl until clear5. Cold StorageRefrigerate 2°C–8°CStable ~28–30 days

5 Standard Reconstitution Steps for Retatrutide

  1. Clean the rubber stoppers of both the Retatrutide vial and the bacteriostatic water vial with fresh 70% isopropyl alcohol prep pads.
  2. Draw the targeted volume of sterile bacteriostatic water (e.g., 2.0 mL) into a sterile mixing syringe.
  3. Insert the needle through the Retatrutide stopper at a 45-degree angle, directing the fluid stream against the inside glass wall rather than directly onto the lyophilized powder cake.
  4. Allow the water to enter slowly without excessive pressure. Gently swirl the vial between your palms until the powder fully dissolves. NEVER shake the vial.
  5. Inspect the solution to confirm complete clarity. Store the reconstituted vial upright in a dark laboratory refrigerator at 2°C–8°C (36°F–46°F).

❄️ Storage & Shelf-Life Notice (Retatrutide)

Reconstituted Retatrutide remains stable under refrigeration (2°C–8°C) for up to 28 days when reconstituted with Bacteriostatic Water containing 0.9% benzyl alcohol. Do not freeze reconstituted liquid solutions, as ice crystal formation causes peptide denaturation.

⚠️ Common Preparation Mistakes to Avoid

A frequent mistake in Retatrutide preparation is shaking the vial rapidly to speed up dissolution. Agitation creates foam and causes shear stress that denatures the glucagon-binding domain. Another error is using unpreserved sterile water, which lacks antimicrobial preservatives and risks contamination within 24 hours.

Retatrutide Dosing FAQ

How much bac water should I add to a 10mg Retatrutide vial?↓
Adding 2.0 mL of bacteriostatic water to a 10 mg Retatrutide vial creates a convenient concentration of 5.0 mg/mL (500 mcg per 10 units on a U-100 syringe). For smaller research doses, adding 3.0 mL creates a concentration of 3.33 mg/mL.
How many syringe units equal a 2.5 mg Retatrutide dose?↓
If your 10 mg vial is reconstituted with 2.0 mL of water (concentration = 5 mg/mL), a 2.5 mg dose equals exactly 50 units (0.50 mL) on a U-100 syringe.
What is the research half-life of Retatrutide?↓
Retatrutide has an estimated terminal half-life of approximately 6 days in human clinical trials, allowing for steady-state pharmacokinetics with weekly research dosing.
Can Retatrutide be frozen after reconstitution?↓
No. While un-reconstituted lyophilized Retatrutide powder can be stored frozen at -20°C long term, reconstituted liquid solutions must NEVER be frozen. Freezing forms micro-ice crystals that damage the peptide structure.
How does Retatrutide differ from Tirzepatide?↓
Retatrutide is a triple agonist targeting GIP, GLP-1, and Glucagon receptors, whereas Tirzepatide is a dual GIP/GLP-1 agonist. Glucagon receptor activation in Retatrutide adds direct stimulation of liver lipid catabolism and higher energy expenditure.

Related Peptide Calculators & Stacks